CV Sciences, Inc. Announces Pre-IND Meeting Date with FDA

May 2, 2017

CV Sciences, Inc. Applauds U.S. Department of Defense Smokeless Tobacco Cessation Campaign

Mar 22, 2017

CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil(TM), at Natural Products Expo West in Anaheim, CA - March 9-12, 2017

Feb 28, 2017

CV Sciences, Inc. to Present at NobleCon13 Annual Investor Conference

Jan 25, 2017

CV Sciences, Inc. to Present at 9th Annual Biotech Showcase

Dec 22, 2016

CV Sciences, Inc. Highlights Major League Baseball (MLB) Decision to Prohibit All New Players From Using Smokeless Tobacco

Dec 20, 2016

CV Sciences, Inc. Provides Details for Webcast Discussing Its CBD-Based Drug Development Program on November 10, 2016

Nov 3, 2016

CV Sciences, Inc. Reports Third Quarter 2016 Financial Results

Nov 2, 2016

CV Sciences, Inc. to Host Webcast on its CBD-based Drug Development Program on November 10, 2016

Oct 28, 2016

CV Sciences, Inc. Issues Letter to Shareholders

Sep 27, 2016